Abstract
The aim of this study was to investigate the incidence of pre-induction coughing, after an iv bolus of fentanyl. The study sample was 250 ASA physical status I-II patients, scheduled for various elective surgical procedures. The first 100 were randomly allocated to recieve 1.5 μg · kg−1 fentanyl via a peripheral venous cannula (Group 1), or an equivalent volume of saline (Group 2). Twenty-eight per cent of patients who received fentanyl, but none given saline, coughed within one minute (P < 0.0001). The second 150 patients were then randomly assigned to three equal pretreatment groups. Group 3 received 0.01 μg · kg-1 atropine iv one minute before fentanyl. Groups 4 and 5 received 0.2 μg · kg-1 morphine im, and 7.5 mg midazolam po, respectively, one hour before fentanyl. Thirty per cent of patients in Group 3, 6% in Group 4, and 40% in Group 5, had a cough response to fentanyl. Fentanyl, when given through a peripheral cannula, provoked cough in a considerable proportion of patients. This was not altéréd by prémédication with atropine or midazolam, but was reduced after morphine (P < 0.01). Coughing upon induction of anaesthesia is undesirable in some patients, and stimulation of cough by fentanyl in unpremedicated patients may be of clinical importance.
Résumé
Le but de cette étude était d’investiguer l’incidence de la toux pré-induction après bolus intraveineux de fentanyl. La population de l’étude était de 250 patients ASA I–II cédulés pour des procédures chirurgicales électives variées. Les premiers 100 patients furent randomisés afin de recevoir 1.5 μg · kg−1 de fentanyl à trovers une canule veineuse périphérique (Groupe 1), ou un volume équivalent de salin (Groupe 2). Vingthuit pour cent des patients y ont reçu du fentanyl mais aucun de ceux qui ont reçu du salin, ont toussé a l’intérieur d’une minute (P < 0,0001). Les 150 autres patients furent ensuite randomises en trois groupes égaux de prétraitement. Le groupe 3 a reçu 0,01 μg · kg−1 d’atropine iv une minute avant le fentanyl et le groupe 4 et 5 ont reçu 0,2 mg · kg−1 de morphine im et 7,5 mg de midazolam po, respectivement, une heure avant le fentanyl. Trente pour cent des patients dans le Groupe 3, 6% dans le Groupe 4, et 40% dans le Groupe 5, ont présenté de la toux lors de l’injéction du fentanyl. Le fentanyl, lorsqu’administré dans une canule périphérique, a provoqué de la toux chez un grand nombre de patients. Ceci ne fut pas altéré par la prémédication avec l’atropine ou le midazolam mais fut réduit après morphine (P < 0,01). La toux lors de l’induction de l’anesthésie n’est pas désirée chez certains patients, et la stimulation de la toux par le fentanyl chez des patients nonprémédiqués peut être d’une importance clinique.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jaffe JH, Martin WR. Opoid analgesics and antagonists. Goodman and Gillman’s The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan Publishing Company. 1985; 491–531.
Sevelius H, McCoy JF, Colmore JP. Dose response to codeine in patients with chronic cough. Clin Pharmacol Ther 1971; 12: 449–55.
Bohrer H, Fleischer F, Werning P. Tussive effects of a fentanyl bolus administered through a central venous catheter. Anaesthesia 1990; 45: 18–21.
Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histaminc: a method and clinical survey. Clin Allergy 1977; 7: 235–43.
Fuller RW, Choudry NB. Patients with a nonproductive cough have an increased cough reflex. Thorax 1989; 255–6P.
Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperrcactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976; 113: 131–9.
Fuller RW, Choudry NB. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. BMJ 1987; 295: 1025–6.
Miller JD, Becker DP, Ward JD, Sullivan HG, Adams WE, Rosner MJ. Significance of intracranial hypertension in severe head injury. J Neurosurg 1977; 47: 503–16.
Giesecke AH, Egbert LD. Anesthesia for trauma surgery. Anesthesia. 2nd ed. New York: Churchill Livingstone Inc. 1986; 1833.
Atkinson RS, Rushman GB, Let JA. A Synopsis of Anaesthesia, 9th ed. First PG Asian Economy Ed. Singapore: PG Publishing Pte Ltd. 1984; 334.
Friel JP. Dorland’s Illustrated Medical Dictionary, 26th ed. Igaku-Shoin/Saundcrs International Ed. Philadelphia: WB Saunders 1982; 312.
Widdicombe JG. Pulmonary and respiratory tract receptors. J Exp Biol 1982; 100: 41–57.
Guz A, Nobel MIM, Eisele JH, Trenchard D. Experimental results of vagal block in cardiopulmonary disease. Breathing: Hering-Breuer Centenary Symposium. London: Churchill 1970; 315–29.
Jain SK, Subramanian S, Julka DB, Guz A. Search for evidence of lung chemoreflexes in man: study of respiratory and circulatory effects of phcnyldiguanide and lobeline. Clin Sci 1972; 42: 163–77.
Sapru HN, Willette BN, Krieger AJ. Stimulation of pulmonary J receptors by an enkephalin-analog. J Pharmacol Exp Ther 1981; 217: 228–34.
Widdicombe JG. Receptors in the trachea and bronchi of the cat. J Physiol 1954; 123: 71–104.
Sant’Ambrogio G, Remmers JE, De Groot WJ, Callas G, Mortola JP. Localisation of rapidly adapting receptors in the trachea and main stem bronchus of the dog. Respir Physiol 1978; 33: 359–66.
Chausow AM, Banner AS. Comparison of tussive effects of histamine and methacholine in humans. J Appl Physiol 1983; 55: 541–6.
Yasuda I, Hirano T, Yusa T, Satoh M. Tracheal constriction by morphine and fentanyl in man. Ancsthesiology 1978; 49: 117–9.
Leff AR. Endogenous regulation of bronchomotor tone. Am Rev Respir Dis 1988; 137: 1198–216.
Reitern JA, Stengen KB, Wymore ML, Martucci RW. Central vagal control of fcntanyl-induced bradycardia during halothanc anesthesia. Anesth Analg 1978; 57: 31–6.
Vidruk EH, Hahn HL, Nadel JA, Sampson SR. Mechanisms by which histamine stimulates rapidly adapting receptors in dog lungs. J Appl Physiol 1977; 43: 397–402.
Hermens JM, Ebern JM, Hanifin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl and oxymorphonc. Ancsthesiology 1985; 62: 124–9.
Leff AR, Slimier NP, Munoz NM, Shioya T, Tallet J, Dame C. Augmentation of respiratory mast cell secretion of histamine caused by vagus nerve stimulation during antigen challenge. J Immunol 1985; 136: 1066–73.
Benthuysen JL, Smith NT, Sanford TJ, Head N, Dec-Silver H. Physiology of alfcntanil-induced rigidity. Anesthesiology 1986; 64: 440–6.
Wand P, Kuschinsky K, Sontag KH. Morphine-induced muscular rigidity in rats. Eur J Pharmacol 1973; 24: 189–93.
Havemann U, Turski L, Schwaz M, Kuschinsky K. On the role of GABA-ergic mechanisms in striatum and substantia nigra in mediating muscular rigidity. Naunyn Schmiedebergs Arch Pharmacol 1983; 322 (Supp): 373.
Haefely WE. Benzodiazepines. Int Anesthesiol Clin 1988; 26: 262–72.
Knoll J. Two kinds of opiate receptors. Pol J Pharmacol Pharm 1977; 29: 165–75.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Phua, W.T., Teh, B.T., Jong, W. et al. Tussive effect of a fentanyl bolus. Can J Anaesth 38, 330–334 (1991). https://doi.org/10.1007/BF03007623
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03007623